Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lieberman

Showing results (901-910 of 1,142) with videos related to

Pageof 115
Sort By:
Genetic Testing and Molecular Biomarkers|July 11, 2012
The AmpliChip® CYP450 test and response to treatment in schizophrenia and obsessive compulsive disorder: a pilot study and focus on cases with abnormal CYP2D6 drug metabolismDaniel J Müller, Eva J Brandl, Rudi Hwang, et al.
Pharmacogenomics|February 22, 2011
Gene-gene interaction analyses between NMDA receptor subunit and dopamine receptor gene variants and clozapine responseRudi Hwang, Renan P Souza, Arun K Tiwari, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 26, 2014
Investigation of melanocortin system gene variants in antipsychotic-induced weight gainNabilah I Chowdhury, Renan P Souza, Arun K Tiwari, et al.
Journal of Psychiatric Research|February 2, 2010
Genetic association of the GDNF alpha-receptor genes with schizophrenia and clozapine responseRenan P Souza, Marco A Romano-Silva, Jeffrey A Lieberman, et al.
British Journal of Obstetrics and Gynaecology|August 1, 1979
The effects of maternally administered pethidine or epidural bupivacaine on the fetus and newbornB A Lieberman, D B Rosenblatt, E Belsey, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2023
Programmable peroxidase-assisted signal amplification enables flexible detection of nucleic acid targets in cellular and histopathological specimensSahar Attar, Valentino E Browning, Yuzhen Liu, et al.
Emerging Infectious Diseases|February 23, 2023
Bartonella spp. Infections Identified by Molecular Methods, United StatesDavid W McCormick, Sara L Rassoulian-Barrett, Daniel R Hoogestraat, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 2, 2019
Randomized, double-blind, placebo-controlled study of F17464, a preferential D<sub>3</sub> antagonist, in the treatment of acute exacerbation of schizophreniaIstvan Bitter, Jeffrey A Lieberman, Florence Gaudoux, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|January 7, 2015
The role of genetic variation across IL-1β, IL-2, IL-6, and BDNF in antipsychotic-induced weight gainTrehani M Fonseka, Arun K Tiwari, Vanessa F Gonçalves, et al.
Pharmacogenomics|December 16, 2015
Preliminary evidence for association of genome-wide significant DRD2 schizophrenia risk variant with clozapine responseEric Huang, Malgorzata Maciukiewicz, Clement C Zai, et al.
Pageof 115

Showing results (901-910 of 1,142) with videos related to

Sort By:
Pageof 115
Genetic Testing and Molecular Biomarkers|July 11, 2012
The AmpliChip® CYP450 test and response to treatment in schizophrenia and obsessive compulsive disorder: a pilot study and focus on cases with abnormal CYP2D6 drug metabolismDaniel J Müller, Eva J Brandl, Rudi Hwang, et al.
Pharmacogenomics|February 22, 2011
Gene-gene interaction analyses between NMDA receptor subunit and dopamine receptor gene variants and clozapine responseRudi Hwang, Renan P Souza, Arun K Tiwari, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 26, 2014
Investigation of melanocortin system gene variants in antipsychotic-induced weight gainNabilah I Chowdhury, Renan P Souza, Arun K Tiwari, et al.
Journal of Psychiatric Research|February 2, 2010
Genetic association of the GDNF alpha-receptor genes with schizophrenia and clozapine responseRenan P Souza, Marco A Romano-Silva, Jeffrey A Lieberman, et al.
British Journal of Obstetrics and Gynaecology|August 1, 1979
The effects of maternally administered pethidine or epidural bupivacaine on the fetus and newbornB A Lieberman, D B Rosenblatt, E Belsey, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2023
Programmable peroxidase-assisted signal amplification enables flexible detection of nucleic acid targets in cellular and histopathological specimensSahar Attar, Valentino E Browning, Yuzhen Liu, et al.
Emerging Infectious Diseases|February 23, 2023
Bartonella spp. Infections Identified by Molecular Methods, United StatesDavid W McCormick, Sara L Rassoulian-Barrett, Daniel R Hoogestraat, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 2, 2019
Randomized, double-blind, placebo-controlled study of F17464, a preferential D<sub>3</sub> antagonist, in the treatment of acute exacerbation of schizophreniaIstvan Bitter, Jeffrey A Lieberman, Florence Gaudoux, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|January 7, 2015
The role of genetic variation across IL-1β, IL-2, IL-6, and BDNF in antipsychotic-induced weight gainTrehani M Fonseka, Arun K Tiwari, Vanessa F Gonçalves, et al.
Pharmacogenomics|December 16, 2015
Preliminary evidence for association of genome-wide significant DRD2 schizophrenia risk variant with clozapine responseEric Huang, Malgorzata Maciukiewicz, Clement C Zai, et al.
Pageof 115